checkAd

     191  0 Kommentare GenMark Diagnostics’ ePlex Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA - Seite 4

    Public Relations Contact
    Lauren Martin
    (815) 592-6296
    lmartin@pcipr.com

    Investor Relations Contact
    Leigh Salvo
    (415) 937-5404
    ir@genmarkdx.com

    Lesen Sie auch

    1 Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395:1054-62.
    2 Weiss, Z.F., et. al. Opportunities Revealed for Antimicrobial Stewardship and Clinical Practice with Implementation of a Rapid Respiratory Multiplex Assay. J Clin Micro. 2019; 57(10):e00861-19.


    Aktuelle Themen


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 4 von 4

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    GenMark Diagnostics’ ePlex Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA - Seite 4 Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu seasonRP2 Panel at a Glance GenMark’s ePlex Respiratory Pathogen Panel 2 (RP2 Panel) has received Emergency Use Authorization …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer